The authors sought to determine whether smoking is related to schizophrenia or neuroleptic treatment.
Cigarette smoking was measured in all patients hospitalized at a state hospital (N=360) and compared in relation to gender and diagnosis (schizophrenic versus nonschizophrenic).
The overall frequency of smoking was 79% (N=284).
Male schizophrenic patients had the highest frequency of smoking, followed by male nonschizophrenic patients, female schizophrenic patients, and female nonschizophrenic patients, respectively.
Schizophrenia and polydipsia were associated with both smoking and heavy smoking.
After correction for other variables, schizophrenia appears to increase the risk of being both a smoker and a heavy smoker.
There was a possible association between high doses of neuroleptics and smoking but only for nonschizophrenic patients.
Mots-clés Pascal : Schizophrénie, Psychose, Facteur risque, Développement maladie, Tabagisme, Chimiothérapie, Traitement, Neuroleptique, Psychotrope, Homme, Epidémiologie
Mots-clés Pascal anglais : Schizophrenia, Psychosis, Risk factor, Disease development, Tobacco smoking, Chemotherapy, Treatment, Neuroleptic, Psychotropic, Human, Epidemiology
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 95-0211139
Code Inist : 002B18C06A. Création : 09/06/1995.